Compliance Blog
Season’s Greetings from Whitelaw Compliance Group
Click to view larger version
Whitelaw Compliance Group Presents at the 19th Annual Pharmaceutical & Medical Device Conference
On Thursday, November 8th, Dr. Seth Whitelaw will be joining a distinguished panel of experts for an interactive discussion on the evolution of the compliance office from “Compliance 1.0 to 3.0”. ...
Open Payments 2.0 – Big Changes Are Forecast
The forecast for transparency just turned cloudy. Key Messages Tucked into the latest opioid law are changes to the Sunshine Act.Beginning in 2022, drug and device companies now must report...
Drug Pricing—The Next Compliance Waterloo
My latest article co-authored with Nicodemo Fiorentino and Jennifer O'Leary is available as a free download from the Mitchell Hamline Law Review. The current drug pricing war pits the...
Whitelaw Compliance Group to Attend West Chester University & Grow PA Discussion about Ethical Decision Making
On Thursday, September 27, 2018, Whitelaw Compliance Group will be attending the open discussion hosted by West Chester University and Grow PA. The discussion will focus on how to provide students...
Have Your Cake & Write a Script Too
Stepping out of her car, Sally Pharmrep glanced again at her watch. If she was late, it would not be well received. Reaching into the back seat of her white, four-door Camry, she pulled out the...
UnitedHealth pushes back in whistleblower case
Check out my commentary in Saturday's (April 14th) Business Section of the Minneapolis Star Tribune.
MISSING THE MARKET: GOVERNMENT STANDARDS ARE UNDERMINING COMPLIANCE EFFORTS IN SMALLER LIFE SCIENCE COMPANIES
First introduced into life sciences more than two decades ago as the result of a government settlement, compliance officers and compliance departments are now considered essential for pharmaceutical...
A Bright Future or Unfulfilled Promise – An Update on Biosimilars and Their Prospects for Contributing to Meaningful Cost Reduction
Biosimilars have a bright future and promise potentially significant health care cost savings, provided the regulatory, legal and commercial hurdles are removed. Recent activity by CVS and United...